Avantax Planning Partners, Inc. Ligand Pharmaceuticals Inc Transaction History

Avantax Planning Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$128.36 - $272.13 $2,695 - $5,714	-21 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$211.18 - $274.49 $4,434 - $5,764	21 New	21 $6,000
Q2 2018 Aug 13, 2018	SELL	$150.77 - $207.98 $4,975 - $6,863	-33 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$138.63 - $182.62 $4,574 - $6,026	33 New	33 $4,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Planning Partners, Inc. with notifications on news.